Roche Calls For U.S. Contract To Guarantee Tamiflu Stockpile
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS is in discussions to purchase enough of the influenza treatment to cover a total of 3% of the U.S. population, Roche tells House hearing on pandemic preparedness. Other countries already have purchase commitments that would cover 20% to 40% of their populations.